|
1
|
Gilead Sciences
Foster City,
California
|
$5.83M
|
–
|
–
|
–
|
|
|
2
|
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
$4.72M
|
+$2.11M
|
+200,419
|
+61%
|
|
|
3
|
Frazier Life Sciences Management
Palo Alto,
California
|
$3.79M
|
+$4.44M
|
+422,507
|
New
|
|
|
4
|
Point72 Asset Management
Stamford,
Connecticut
|
$2.56M
|
+$3M
|
+285,714
|
New
|
|
|
5
|
Sio Capital Management
New York
|
$1.37M
|
+$1.6M
|
+152,467
|
New
|
|
|
6
|
Stempoint Capital
New York
|
$1.3M
|
+$1.52M
|
+145,002
|
New
|
|
|
7
|
Merck & Co
Rahway,
New Jersey
|
$950K
|
–
|
–
|
–
|
|
|
8
|
Vanguard Group
Malvern,
Pennsylvania
|
$804K
|
–
|
–
|
–
|
|
|
9
|
Empery Asset Management
New York
|
$757K
|
+$888K
|
+84,503
|
New
|
|
|
10
|
Ghisallo Capital Management
Boston,
Massachusetts
|
$713K
|
+$835K
|
+79,516
|
New
|
|
|
11
|
|
$538K
|
-$91.6K
|
-8,719
|
-13%
|
|
|
12
|
AJU IB Investment Company
Seoul,
South Korea
|
$427K
|
–
|
–
|
–
|
|
|
13
|
Fidelity Investments
Boston,
Massachusetts
|
$328K
|
–
|
–
|
–
|
|
|
14
|
Citadel Advisors
Miami,
Florida
|
$279K
|
+$327K
|
+31,158
|
New
|
|
|
15
|
Renaissance Technologies
New York
|
$220K
|
+$105K
|
+9,980
|
+68%
|
|
|
16
|
Geode Capital Management
Boston,
Massachusetts
|
$211K
|
–
|
–
|
–
|
|
|
17
|
State Street
Boston,
Massachusetts
|
$119K
|
+$16.9K
|
+1,608
|
+14%
|
|
|
18
|
Velan Capital Investment Management
Alpharetta,
Georgia
|
$109K
|
+$128K
|
+12,143
|
New
|
|
|
19
|
GSA Capital Partners
London,
United Kingdom
|
$95K
|
+$111K
|
+10,569
|
New
|
|
|
20
|
Stonepine Capital Management
Bend,
Oregon
|
$80.8K
|
+$94.7K
|
+9,019
|
New
|
|
|
21
|
Northern Trust
Chicago,
Illinois
|
$42.6K
|
–
|
–
|
–
|
|
|
22
|
Two Sigma Investments
New York
|
$39.7K
|
-$19.3K
|
-1,840
|
-29%
|
|
|
23
|
Bridgeway Capital Management
Houston,
Texas
|
$35.9K
|
–
|
–
|
–
|
|
|
24
|
|
$26.9K
|
+$31.6K
|
+3,006
|
New
|
|
|
25
|
|
$20K
|
+$5.37K
|
+511
|
+29%
|
|
